------------------------------
OMB APPROVAL
------------------------------
OMB Number 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response ........ 11
------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Genomed, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
37243C 10 2
--------------------------------------------------------------------------------
(CUSIP Number)
L. S. Robins
8301 Washington NE
Albuquerque, N.M. 87113
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March 11, 2004
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or
240.13d-1(g), check the following box [_].
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for
other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 37243C 10 2
--------------------------------------------------------------------------------
1. Name of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Advanced Optics Electronics, Inc. 88 0365136
-------------------------------------------------------------------
--------------------------------------------------------------------------------
2. Check the Appropriate Box If a Member of a Group (See Instructions)
(a) [ ]
----------------------------------------------------
(b) [ ]
----------------------------------------------------
--------------------------------------------------------------------------------
3. SEC Use Only
----------------------------------------------------
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions) WC
------------------------------------------------------------
------------------------------------------------------------------------------
5. Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d)
or 2(e) [ ]
-----------------------------------------------------------------
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization Nevada
---------------------------------
--------------------------------------------------------------------------------
7. Sole Voting Power 33,000,000 shares
--------------------------------
NUMBER OF
SHARES _________________________________________________________________
BENEFICIALLY
OWNED BY 8. Shared Voting Power
EACH ---------------------------------
REPORTING _________________________________________________________________
PERSON
WITH 9. Sole Dispositive Power
----------------------------
-----------------------------------------------------------------
10. Shared Dispositive Power
---------------------------
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person 33,000,000
--------------
--------------------------------------------------------------------------------
12. Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions) [ ]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) 21.12 %
------------------
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
CO
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
--------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
March 22, 2004
----------------
Date
L.S. Robins
-----------------------------
Signature
Executive Vice President
----------------------------------
Name/Title
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement: provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)